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Abstract: Background — Melasma is a chronic acquired localized hypermelanosis, causing aesthetic problem for women and impairing 
their quality of life. Evidence has suggested that hyperpigmentation can occur as a result of iron deficiency anemia and vitamin B12 
deficiency.  
Aim — We aimed to evaluate the serum parameters of iron profile in melasma patients. 
Material and Methods — This case-control study investigated 51 adult non pregnant women with melasma, compared with 51 controls, 
from patients referred to the Hospital, Tehran, Iran, 2017–2018. Melasma was diagnosed clinically according to the melasma area and 
severity index (MASI) score was calculated and recorded by the physician. The groups were compared in terms of vitamin B12, folate, serum 
iron, hemoglobin (Hb), mean corpuscular volume (MCV), total iron binding capacity (TIBC), and ferritin.  
Results — The mean and standard deviation of the women’s age was 36.89±8.88 years, significantly higher in the group of patients with 
melasma. Comparing the serum parameters between the groups indicated no statistically significant difference in terms of mean levels of 
ferritin, Hb, MCV, iron, vitamin B12, TIBC, and folate. The women in melasma group had a higher frequency in below normal range of 
ferritin and serum iron compared to the control group. None of the serum parameters were correlated with MASI. 
Conclusion — The higher frequency of below normal range of ferritin and serum iron levels in women with melasma compared to the 
control group showed a possible association between these serum parameters and melasma. 
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Introduction  
Melasma is a chronic acquired disease of the skin, caused by 
melanogenesis dysfunction [1], resulting in localized hypermelanosis 
[2]. Although medically considered a benign lesion, the aesthetic 
complication of melasma can impair women’s quality of life and 
raise psychological concerns in the affected patients [3]. As to the 
evidence, melasma occurs in all races, ethnic populations, and 
geographic areas; however, the incidence of melasma in the 
generalpopulation is not clear and most studies describe the 
prevalence only according to the dermatologic visits [2, 4]. 
Generally, a higher prevalence is reported in populations with a 
darker skin phenotypes (Fitzpatrick III and IV), including Hispanic and 
Latin Americans, Asians, Middle Eastern and Africans [5] and a 
prevalence of about 40% is reported in Iranian women [6].  
Although the exact pathogenesis of melasma is uncertain, a 
combination of genetic predisposition, in addition to environmental 
factors, like sun exposure, have been suggested to play a role in its 
higher incidence in summer on exposed parts of the body [4]. The 
higher incidence in women, especially during pregnancy, is also 
attributed to the role of female hormones on occurrence of 
melasma [7]. Hence, as melasma requires long–term treatment and 
the exact etiology is still unclear [8], research has focused on the 
underlying and attributing factors [9] in order to take a step towards 
a better understanding of the disease. In this regard, several serum 
parameters, like zinc, iron, copper, and magnesium, have been 
associated with skin lesions and melasma [10, 11]. Vitamin B12 
deficiency is also associated with hyperpigmentation [12] and vitiligo 
[13]. However, its association with melasma is doubted [14].  
Iron deficiency anemia is a public health problem with the 
highest prevalence in women of reproductive age [15] the same 
population susceptible for melasma. Evidence has suggested that 
hyper pigmentation can occur as a result of iron deficiency anemia 
and patients with melasma have been reported to have a lower 
serum levels of hemoglobin (Hb), iron, ferritin and total iron binding 
capacity (TIBC) [14, 16, 17]. Hence, these studies had several 
limitations, such as limited sample size and not controlling the effect 
of confounders, like endocrine disorders and using medications like 
oral contraceptives, which could affect the results. Therefore, for a 
definite conclusion, we aimed to compare the serum levels of 
vitamin B12, folate, serum iron, Hb, mean corpuscular volume (MCV), 
TIBC, and ferritin between nonpregnant women with and without 
melasma controlling for confounders. 
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Table 1. Comparing serum measurements between melasma and control groups adjusted for age in linear regression  
Variant Normal range, laboratory measurement method and device name Melasma Control P–value 
Ferritin, ng/ml 10–90, BT 3000 35.11±38.13 36.73±24.68 0.274 
Hemoglobin, g/dl 12–16, Full diff Sismex 13.05±0.98 13.07±0.79 0.986 
MCV, fl 77–97 femtoliter 86.93±4.95 84.88±5.61 0.589 
Serum iron, micg/dl 40–155, Full diff Sismex 65.90±31.90 61.72±24.39 0.403 
TIBC, micg/dl 230–440, BT 3000 337.47±49.12 316±49.44 0.055 
Vitamin B12, pg/ml 211–946, electrochemiluminescence, (ECL, made in Germany, 2010) 341.45±212.56 374±146.56 0.491 
Folate, ng/ml 4.6–34.8, electrochemiluminescence, (ECL, made in Germany, 2010) 11.01±6.25 13.13±6.04 0.058 
Data presented as mean with standard deviation – M±SD. 
 
 
Table 2. Comparison the characteristics of the women in melasma and 
control group 
M±SD – data presented as mean with standard deviation; n (%) – data 
presented as numbers and percentages. 
 
 
Material and Methods 
Study sample 
The present case-control study investigated women with 
melasma who referred to the Dermatology Ward of the Rasoul 
Akram Hospital, Tehran, Iran, during 2017–2018.  
The sample size was calculated at 51 in each group based on 
the mean serum iron level of the study by Qazi and colleagues [17], 
considering type I and II error of 0.05 and 0.20, respectively. 
Accordingly, a total of 102 women were investigated in two groups: 
51 patients in the case group and 51 patients in the control group. 
The inclusion criteria for both groups consisted of adult non–
pregnant women aged 20 to 50 years old, with normal body mass 
index (BMI) (18.5–25 kg/m2), without autoimmune, thyroid or 
cardiac disease, pernicious anemia, celiac disease, Crohn’s disease, 
leukemia, or cancer, and without history of hormone replacement 
therapy, alcohol use, smoking, oral contraceptive pills (OCP), 
phototoxic drugs, phenytoin, spironolactone, vitamin B12, and folic 
acid during last six months, who referred to the selected hospital’s 
ward during the study period. Furthermore, the participants 
without vegetarian habit were included. 
The participants of the case group were selected from patients 
with melasma by convenient sampling method from who referred to 
the Dermatology Ward of the hospital and participants of the control 
group were selected from patients who referred to other wards of the 
hospital, rather than dermatology, who were included by matching 
each control with each case. Patients were included into the study, 
after the researcher explained the study objectives and methods to 
the participants and asked them to read and sign the written informed 
consent, if they desired to participate in the study. They were ensured 
that all their information will be kept confidential and analyzed 
without revealing their personal information.  
 
Melasma diagnosis 
For the case group, all patients were visited by the clinic’s 
physician and diagnosis of melasma was made clinically, by wood 
lamp, after ruling out other dermatologic/inflammatory disorders 
[18]. Also, themelasma area and severity index (MASI) score [19] 
was calculated by the physician and recorded in the study checklist.  
 
Variables 
For measurement of vitamin B12, folate, serum iron, Hb, MCV, 
TIBC, and ferritin, 15 cc venous blood sample was taken from 
participants of both groups, kept in refrigerator, and sent to the 
hospital’s laboratory immediately. Normal range of the serum 
parameters, the laboratory measurement techniques, and devices 
used are shown in Table 1. 
 
Statistical analysis 
Numbers with percentage and mean with standard deviation 
(M±SD) were used to describe qualitative and quantitative 
variables, respectively. Independent sample t–test was used to 
compare the quantitative variables with normal distribution. 
Kolmogorov-Smirnov test was used to investigate normality 
assumption. The comparison of the serum parameters between 
groups adjusted for significant covariates were done using multiple 
linear regression and logistic regression. Pearson’s correlation 
coefficient was calculated to evaluate the association between the 
MASI scores and the serum parameters. The statistical software 
IBM SPSS Statistics for Windows, Version 22.0 (IBM Corp. Released 
2013. Armonk, NY: IBM Corp), was used for statistical analysis. P-
value less than 0.05 were considered significant. 
 
Results 
This study was completed by 51 women in the case group (with 
melasma) and 51 women without melasma (as the control group). 
The mean ±SD of the women’s age was 36.89±8.88 years. Table 2 
shows that the characteristics of the women in melasma and 
control group were homogenous (P>0.05) except women’s mean 
age which had a statistically significant difference between case 
and control groups (41.45±6.18 vs. 32.33±8.86, respectively) 
(P<0.001). Quantitative variables did not deviated from normality 
assumption (P>0.5). 
 
P–value Control Melasma  Characteristic 
<0.001 32.33±8.86 41.45±6.18 - Age, year, M±SD 
0.074    Family history of melasma 
 20 (39) 29 (57) Yes 
 31 (61) 22 (43) No 
0.192    Using sunscreen, n (%)  
   19 (37) 29 (57) Yes 
 32 (63) 22 (43) No 
0.685    Employment, n (%) 
 30 (59) 32 (63) housewife 
 21 (41) 19 (37) Employed 
0.308    Marital status, n (%) 
 50 (98) 48 (94) Married 
 1 (1) 3 (6) Single 
0.295    Duration expose to sun 
(hour), n (%)  16 (32) 10 (19) <1 
 30 (60) 34 (67) 1-2 
 4 (8) 7 (14) >2 
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Table 3. Odds Ratio (95% confidence interval (CI)) for each serum 
parameter between the case and control groups adjusted for age 
Serum 
parameter 






<10 17(33) 5(9.8) 4.07 (1.2, 13.8) 0.023 
10–90* 29(56.9) 44(86.3) 1  
>90 5(9.8) 2(3.9) 0.93 (0.11, 7.53) 0.940 
Hemoglobin,  
g/dl 
<12 5(9.8) 5(9.8) 1.22 (0.27, 5.63) 0.791 
>12 46(90.2) 46(90.2) 1  
MCV, fl <77 1(2) 3(5.9) 0.73 (0.06, 8.5) 0.800 
77–97* 49(96.1) 48(94.1) 1  
>97 1(2) 0(0) -  
Iron, 
micg/dl 
<40 11(21.6) 5(9.8) 3.99 (1.04, 15.25) 0.042 
40–155* 39(76.5) 46(90.2) 1  
>155 1(2) 0(0) -  
TIBC,  
micg/dl 
<230 1(2) 2(3.9) 1.4 (0.09, 21.8) 0.814 
230–440* 49(96.1) 49(96.1) 1  
>440 1(2) 0(0) -  
Vitamin B12,  
pg/ml 
<211 13(25.5) 5(9.8) 3.47 (0.95, 12.6) 0.058 
211–946* 36(70.6) 46(90.2) 1  
>946 2(3.9) 0(0) -  
Folate,  
ng/ml 
<4.6 4(7.8) 1(2) 5.7 (0.51, 63.1) 0.158 
4.6–34.8* 47(92.2) 50(98) 1  
>34.8 0(0) 0(0) -  
* Normal range was considered as the reference group, † Significant 
difference, in the case of zero frequency, the associated cell is omitted in 
the logistic regression modelling. 
 
Table 4. The Pearson’s correlation coefficient between the MASI score 
and the serum parameters 
Variant  Correlation P-value 
Ferritin  -0.11 0.45 
Hemoglobin  -0.10 0.48 
MCV 0.20 0.15 
Iron 0.03 0.81 
TIBC -0.15 0.29 
Vitamin B12 0.16 0.24 
Folate  -0.03 0.83 
 
 
The patients’ serum parameters are compared between the 
groups in Table 2. As indicated, there was no statistically 
significant difference between the groups in mean serum levels 
offerritin, Hb, MCV, iron, vitamin B12, TIBC, and folate adjusted for 
female age (P>0.05). 
The serum parameters were categorized based on the normal 
range of each serum parameter and compared between the 
groups as shown in Table 3. It was showed that the odds of 
melasma for the female with below normal range of ferritin level 
(<10) was 4.07 (1.2, 13.8) than the odds of melasma for the female 
with normal ferritin level (P=0.023). The female with below normal 
range of iron level had the risk of melasma 3.99 (1.04, 15.25) than 
the female with normal iron level (P=0.042). In addition, below 
normal range level of MCV decreased risk of female’s melasma, 
however, it was not statistically significant (Table 3, P=0.814). It 
was observed that the risk of melasma was higher in females with 
below normal range level of HB (P=0.79), Vitamin B12 (P=0.058), 
and folate (P=0.158) in comparison to the females with that of in 
normal range. It was observed that the risk of melasma was lower 
in females with below normal range level of TIBC (P=0.814) and 
MCV (P=0.8) in comparison to the females with that of in normal 
range. 
Table 4 shows the assessment of the correlation between 
MASI and serum parameters in which none of the serum 
parameters were significantly associated with MASI (P>0.05).  
 
Discussion 
This study showed a higher frequency of below normal range 
ferritin level and serum iron levels in women with melasma, 
compared to the control group. Risk of melasma for the female 
with below normal range of ferritin level as well as iron was 
significantly higher than that of the patients with normal level 
which could imply the role of these serum parameters on 
melasma. 
According to the evidence, hyperpigmentation is a symptom of 
vitamin B12 deficiency, presenting prior to neurologic symptoms 
[20]. Vitamin B12 is an important cofactor for methionine 
synthaseand its deficiency results in impaired methylation and 
DNA synthesis of haemoglobin and accumulation of homocysteine 
[21]. In melanogenesis, hyperpigmentation occurs due to 
depletion of intracellular glutathione, which inhibited tyrosinase 
activity [12]. Babaie and colleagues tested the serum level of 
vitamin B12 in melasma and reported that only 1/70 had a deficient 
vitamin B12 level, while in the present study 13/51 women (25.5%) 
had a deficient vitamin B12 level. This discrepancy between the 
results of the studies can be due to the different inclusion and 
exclusion criteria, as we excluded all patients who have used folic 
acid or vitamin B12supplementation, as well as different cut-off 
levels determined for vitamin B12 deficiency. In addition, Babaie et 
al did not compare the results with a control group. In our study, 
comparing the frequency of vitamin B12 deficiency between the 
case and controls revealed a nonsignificant association between 
melasma and vitamin B12 deficiency. Although studies have 
determined the role of vitamin B12 deficiency in different skin 
lesions and hyperpigmentation) [12, 13, 22], no other study has 
determined its deficiency in patients with melasma, and this study, 
as far as the authors are concerned, is the first to compare its level 
with a control group with nonsignificant association. 
Moreover, it was found that the mean serum levels of Hb, 
MCV, iron, vitamin B12, TIBC, and folate were not different 
between the groups. Moreover, Hb, MCV, vitamin B12, TIBC, and 
folate these serum parameters were not associated with melasma 
risk. 
TIBC represents the sum of all iron binding sites on transferrin, 
which tightly binds to the cell receptor and controls iron release 
into plasma; serum iron will be used by various cells and excess 
levels of iron will be stored as metabolically inactive form, ferritin 
[23]. TIBC is thus measured in diagnosis of iron deficiency anemia, 
iron overload, and chronic inflammatory disorders [24, 25]. The 
higher TIBC level in women with melasma showed lower iron 
storage, although the majority of the patients in both groups was 
within the normal range of TIBC. The lower iron storage of the 
patients with melasma was confirmed by a higher frequency of 
below normal range ferritin level. The results of the present study 
indicated that women with melasma have a higher frequency of 
anemia, and also have a lower iron storage. Also, the nutritional 
habits of patients can significantly affect the serum levels of these 
parameters, although we excluded vegetarians to minimize the 
confounding effect of nutrition on melasma and iron profile. 
Behrangi and colleagues compared the iron profile of 33 women 
with melasma with a control group and reported no significant 
difference between the groups in serum iron, ferritin or TIBC [16]. 
Their results confirmed that of the present study on no difference 
between the patients with melasma and the control group in 
terms of TIBC, but were inconsistent with the results of the 
present study in terms of serum ferritin and serum iron levels. This 
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discrepancy could be due to the difference of the baseline serum 
level of ferritin and serum iron in the study population. In the 
present study, we tried to exclude any patients with chronic 
diseases or supplementation use to control the confounders 
affecting TIBC, serum iron, and ferritin levels. Babaie et al reported 
low Hb and serum iron levels in 14.3% and 8.6% of women with 
melasma [14], while in the present study, 9.8% of patients with 
melasma had low Hb level and 21.6% had low serum iron level. 
This difference can be attributed to the different frequency of 
anemia in different populations and may also differ according to 
the underlying diseases and different age groups of the studied 
population [15]. In the present study, the mean age of the groups 
had significant differences, which could also be attributed to 
different iron profile, so we adjusted the analysis regarding the 
age difference. The study by Qazi et al (2017), comparing 70 
nonpregnant women with melasma and the control group, 
showed a lower mean serum iron and ferritin levels, beside a 
higher TIBC in the case group [17]. These results showed a higher 
frequency of anemia and lower iron storage in women with 
melasma, which was consistent to the results of the present study, 
although the Hb and TIBC levels did not differ between the groups 
in our study and lower iron storage, was indicated by the lower 
mean serum iron and higher frequency of below normal range 
ferritin level. These results could indicate that women with 
melasma had low iron levels and storage, but as far as evident in 
thevitaminB12 and folate although mean levels were lower in 
melasma group but they were not expressive enough, which could 
be followed by future studies. 
In the present study, all variables were tested for association 
with MASI, but the results showed no significance. On the contrary 
to these results, Qazi et al stated a positive correlation between 
MASI score and iron profile [17], which could be also due to the 
lower mean serum iron in the study by Qazi et al, while only 
reduced iron storage was detected in the patients of the present 
study.  
Anemia is a prevalent health problem, especially in women of 
reproductive age [15], who are the main target population of 
melasma, a disturbing skin disease in women, impairing patients’ 
quality of life [3]. The target population of the highest frequency of 
anemia and melasma are the same. Furthermore, the frequency of 
melasma seems to be higher in pregnant women due to the 
increased levels of placental, ovarian and pituitary hormones, 
which results in increased transcription of tyrosinase and 
dopachrome tautomerase and pigmentation during pregnancy [2, 
26]. The same population, pregnant women, have a high 
frequency of anemia [27]. These two, the higher frequency of 
anemia and melasma during pregnancy, may be associated with 
each other, which have to be further investigated. In the present 
study, we did not include pregnant women, due to the complex 
situations and hormone secretion in pregnancy, which may affect 
this association. 
The present study could successfully compare all these 
parameters between the case and control groups, while the one 
study investigating all these parameters had the major limitation 
of a small sample size. Like any other study, our study could also 
have several limitations. First, the participants did not match with 
each other in terms of demographics. Second, all participants were 
selected from one center that reduce the generalizability of the 
results. Furthermore, the case-control nature of the study limited 
confirming causal relationships, although there was no statistically 
significant association between the variables. Meanwhile, as the 
first valid study to investigate this association in an Iranian 
population, the present study could provide valuable information 
for the researchers and clinicians. 
 
Conclusion  
The results of the present study showed that the iron profile of 
women with melasma is different from that of controls. The higher 
frequency of below normal range ferritin and serum iron levels in 
the case group showed the possible role of anemia in melasma.  
 
Limitations 
Although lower frequency of above normal range vitamin B12 
and folate showed a lower iron storage in women with melasma, 
the initial hypothesis of the study (the association of melasma as 
hyperpigmentation with vitamin B12 and serum folate deficiency) 
was not confirmed, as hemoglobin and MCV levels were not 
different between the groups. Although we excluded possible 
factors that could affect vitaminB12 and serum folate levels and 
pathogenesis of hyperpigmentation and melasma, there could be 
several factors affecting the two multifactorial diseases, vitaminB12 
deficiency and melasma, which could not be controlled in the 
present study. Future randomized clinical trial or cohort studies 
can shed light on the association between serum folate and 
vitaminB12 and melasma. 
 
Ethical approval 
 The study was approved by the Ethics Committee of Iran University of 
Medical Sciences (code: IR.IUMS.FMD.REC1395.08921215097), and has 
been performed in accordance with the ethical standards as laid down in 
the 1964 Declaration of Helsinki and its later amendments or comparable 
ethical standards. Informed consent was given to all participants. 
 
Acknowledgement 
The authors would like to thank the Rasoul Akram Hospital Clinical 
Research Development Center (RCRDC) for its technical and editorial 
assists.  
 
Conflict of interest 
The authors declare that they have no conflict of interest. 
 
References 
1. Kang HY, Suzuki I, Lee DJ, Ha J, Reiniche P, Aubert J, et al. 
Transcriptional profiling shows altered expression of wnt pathway- and 
lipid metabolism-related genes as well as melanogenesis-related genes 
in melasma. J Invest Dermatol 2011; 131(8): 1692-1700. 
https://doi.org/10.1038/jid.2011.109.  
2. Handel AC, Miot LD, Miot HA. Melasma: a clinical and epidemiological 
review. An Bras Dermatol 2014; 89(5): 771-782. 
https://doi.org/10.1590/abd1806-4841.20143063.  
3. Katsambas A, Soura E. Quality of life in melasma. In: Melasma and 
vitiligo in brown skin. E. Handog, M. Enriquez-Macarayo, eds. New 
Delhi: Springer, 2017: 169-175. https://doi.org/10.1007/978-81-322-
3664-1_18.  
4. Bagherani N, Gianfaldoni S, Smoller B. An overview on melasma. 
Pigmentary Disorders 2015; 2(10): 218. https://doi.org/10.4172/2376-
0427.1000216.  
5. Khoza N, Dlova N, Mosam A. Epidemiology and global distribution of 
melasma. In: Melasma: a monograph 1st ed. New Delhi: Jaypee 
Brothers Medical Publisher, 2015: 1-3. 
https://doi.org/10.5005/jp/books/12401_2.  
 
ISSN 2304-3415, Russian Open Medical Journal 5 of 5 





© 2020, LLC Science and Innovations, Saratov, Russia www.romj.org 
 
6. Edalatkhah H, Amani F, Rezaifar G. Prevalence of melasma in women 
in Ardebil city in 2002. Iran J Dermatol 2004; 7(2): 72-77. 
https://www.sid.ir/en/journal/ViewPaper.aspx?ID=48038.  
7. Mahmood K, Nadeem M, Aman S, Hameed A, Kazmi AH. Role of 
estrogen, progesterone and prolactin in the etiopathogenesis of 
melasma in females. J Pak Assoc Dermatol 2016; 21(4): 241-247. 
http://www.jpad.com.pk/index.php/jpad/article/view/483.  
8. Lajevardi V, Ghayoumi A, Abedini R, Hosseini H, Goodarzi A, Akbari Z, 
et al. Comparison of the therapeutic efficacy and safety of combined 
oral tranexamic acid and topical hydroquinone 4% treatment vs. 
topical hydroquinone 4% alone in melasma: a parallel-group, assessor- 
and analyst-blinded, randomized controlled trial with a short-term 
follow-up. J Cosmet Dermatol 2017; 16(2): 235-242. 
https://doi.org/10.1111/jocd.12291.  
9. Amin N, Mashhood AA, Bilal A. Association of epidermal melasma with 
skin phenotypes and other contributing factors. J Pak Assoc Dermatol 
2016; 26(3): 188-192. 
https://pdfs.semanticscholar.org/7197/6346aaa4dbcb9a41f6bb81031
99f18e7b022.pdf.  
10. Rostami Mogaddam M, Safavi Ardabili N, Iranparvar Alamdari M, 
Maleki N, Aghabalaei Danesh M. Evaluation of the serum zinc level in 
adult patients with melasma: Is there a relationship with serum zinc 
deficiency and melasma? J Cosmet Dermatol 2018; 17(3): 417-422. 
https://doi.org/10.1111/jocd.12392.  
11. Ping W, Guohua L, Huihui L, Zhengwen W. Determination of trace 
elements in pregnant and non-pregnant patients with melasma. Trace 
Elem Sci 1997; 8. http://en.cnki.com.cn/Article_en/CJFDTotal-
GWYS199708006.htm.  
12. Niiyama S, Mukai H. Reversible cutaneous hyperpigmentation and 
nails with white hair due to vitamin B 12 deficiency. Eur J Dermatol 
2007; 17(6): 551-552. https://doi.org/10.1684/ejd.2007.0285.  
13. Karadag AS, Tutal E, Ertugrul DT, Akin KO, Bilgili SG. Serum 
holotranscobalamine, vitamin B12, folic acid and homocysteine levels in 
patients with vitiligo. Clin Exp Dermatol 2012; 37(1): 62-64. 
https://doi.org/10.1111/j.1365-2230.2011.04142.x.  
14. Najad SB, Khodaiiani E, Herizchi H, Mehrabi P. Frequency of iron 
deficiency anemia, folate and vitamin B12 deficiency in patients with 
melasma. Med J Tabriz Univ Med Sci 2012; 34(2): 12-15. 
https://www.sid.ir/en/journal/ViewPaper.aspx?id=284349.  
15. WHO. The global prevalence of anaemia in 2011. Geneve: World 
Health Organization, 2015; 43 p. 
https://apps.who.int/iris/handle/10665/177094.  
16. Behrangi E, Baniasadi F, Esmaeeli S, Hedayat K, Goodarzi A, Azizian Z. 
Serum iron level, ferritin and total iron binding capacity level among 
nonpregnant women with and without melasma. J Res Med Sci 2015; 
20(3): 281-283. https://www.ncbi.nlm.nih.gov/pubmed/26109976.  
17. Qazi I, Dogra NK, Dogra D. Serum Iron profile in Female patients of 
Melasma: A case control study. Asian Pac J Health Sci 2017; 4 (2): 141-
146. https://doi.org/10.21276/apjhs.2017.4.2.24.  
18. Dermatology atlas for skin of color. D. Jackson-Richards, A.G. Pandya, 
eds. Berlin: Springer-Verlag Berlin Heidelberg, 2014; 321 p. 
https://doi.org/10.1007/978-3-642-54446-0.  
19. Pandya AG, Hynan LS, Bhore R, Riley FC, Guevara IL, Grimes P, et al. 
Reliability assessment and validation of the melasma area and severity 
index (MASI) and a new modified MASI scoring method. J Am Acad 
Dermatol 2011; 64(1): 78-83. 
https://doi.org/10.1016/j.jaad.2009.10.051.  
20. Stabler SP. Clinical practice. Vitamin B12 deficiency. N Engl J Med 
2013; 368(2): 149-160. https://doi.org/10.1056/NEJMcp1113996.  
21. Kräutler B. Vitamin B12: chemistry and biochemistry. Biochem Soc 
Trans 2005; 33(Pt 4):806-810. https://doi.org/10.1042/BST0330806.  
22. Kannan R, Ng MJ. Cutaneous lesions and vitamin B12 deficiency: an 
often-forgotten link. Can Fam Physician 2008; 54(4): 529-532. 
https://www.ncbi.nlm.nih.gov/pubmed/18413300.  
23. Soldin OP, Bierbower LH, Choi JJ, Choi JJ, Thompson-Hoffman S, Soldin 
SJ. Serum iron, ferritin, transferrin, total iron binding capacity, hs-CRP, 
LDL cholesterol and magnesium in children; new reference intervals 
using the Dade Dimension Clinical Chemistry System. Clin Chim Acta 
2004; 342(1-2): 211-217. https://doi.org/10.1016/j.cccn.2004.01.002.  
24. Gottschalk R, Wigand R, Dietrich CF, Oremek G, Liebisch F, Hoelzer D, 
et al. Total iron-binding capacity and serum transferrin determination 
under the influence of several clinical conditions. Clin Chim Acta 2000; 
293(1-2): 127-138. https://doi.org/10.1016/s0009-8981(99)00242-9.  
25. Taher AT, Musallam KM, Inati A. Iron overload: consequences, 
assessment, and monitoring. Hemoglobin 2009; 33 Suppl 1: S46-S57. 
https://doi.org/10.3109/03630260903346676.  
26. Moin A, Jabery Z, Fallah N. Prevalence and awareness of melasma 
during pregnancy. Int J Dermatol 2006; 45(3): 285-288. 
https://doi.org/10.1111/j.1365-4632.2004.02470.x.  
27. Esmat B, Mohammad R, Behnam S, Shahrzad M, Soodabeh T, Minoo A, 
et al. Prevalence of iron deficiency anemia among Iranian pregnant 
women; a systematic review and meta-analysis. J Reprod Infertil 2010; 
11(1): 17-24. https://www.ncbi.nlm.nih.gov/pubmed/23926476.  
 
Authors: 
Azadeh Goodarzi – MD, Assistant Professor, Department of Dermatology, 
Rasoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran. 
https://orcid.org/0000-0002-1249-4429.  
Elham Behrangi – MD, Associate Professor, Department of Dermatology, 
Rasoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran. 
https://orcid.org/0000-0002-6545-3460.  
Afsaneh Sadeghzadeh Bazargan – MD, Assistant Professor, Department of 
Dermatology, Rasoul Akram Hospital, Iran University of Medical Sciences, 
Tehran, Iran. https://orcid.org/0000-0003-1102-6241.  
Masoomeh Rohaninasab – MD, Assistant Professor, Department of 
Dermatology, Rasoul Akram Hospital, Iran University of Medical Sciences, 
Tehran, Iran. https://orcid.org/0000-0002-2862-6422.  
Fatemeh Sadat Hosseini-Baharanchi – MA, MS, PhD, Assistant Professor, 
Minimally Invasive Surgery Research Center, & Department of Biostatistics, 
School of Public Health, Iran University of Medical Sciences, Tehran, Iran. 
https://orcid.org/0000-0003-1633-2635/  
Mahsa Shemshadi – MD, Resident of Dermatology, Rasoul Akram Hospital, 
Iran University of Medical Sciences, Tehran, Iran. https://orcid.org/0000-
0002-6912-0532.  
Elham Vafaei – MD, General Practitioner, Rasoul Akram Hospital, Iran 
University of Medical Sciences, Tehran, Iran. https://orcid.org/0000-0002-
5684-6625.  
 
 
